Skip to main content
OpenTrials
Completed

NCT Number: NCT01478061

Multi-center Assessment of Grafts in Coronaries: Long-term Evaluation of the C-Port Device

The Study plan is a post-market prospective, multi-center, open-label registry. The vein graft failure rates for the currently commercialized C-Port devices will be compared to an a priori rate taken from the peer-reviewed literature.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

University of Arkansas, Little Rock, Arkansas, United States

Loading trial locations.

About this study

To satisfy the requirements set forth in post-market surveillance orders issued by the US FDA to Cardica, Inc., the following outcomes will be evaluated:

  • Acute, midterm, and one-year graft failure rates for coronary revascularization using the C-Port® xA™ Distal Anastomosis System, C-Port® FlexA™ Distal Anastomosis System, and C-Port® XCHANGE™ Distal Anastomosis System when in general use in the United States compared to hand-sewn anastomoses.
  • Technical failure rates when attempting to complete an anastomosis using the C-Port xA, FlexA, and XCHANGE Distal Anastomosis Systems.
  • The technical success rate of hand-sewn anastomoses following technical failures of the C-Port devices and the hand-sewn graft patency rates and clinical sequelae at one year.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Able to give informed consent.
  • Willing and able to have follow-up visits and examinations.
  • Less than 80 years old.
  • Have an ejection fraction of >30 %.
  • Have a life expectancy of >1 year.

Pre-Operative Exclusion Criteria:

  • Currently participating in other clinical trials that would conflict with this protocol.
  • Unable to meet study requirements.
  • Currently pregnant.
  • Require preoperative use of an intraaortic balloon pump.
  • Have a history of a bleeding disorder or history of a thromboembolic disease requiring anticoagulation therapy.
  • Have congestive heart failure or been classified as NYHA Class IV.
  • Have an aspirin allergy or other contraindications to aspirin use.
  • Previous coronary artery bypass surgery.
  • Vasculitis or other nonatherosclerotic cause for coronary artery disease.

Intra-Operative Exclusion Criteria:

  • At least one target vessel site where the C-Port anastomosis will be placed that is free from severe calcification or severe atheromas
  • Target vessel wall properties where the C-Port anastomosis will be placed are suitable for hand-sewn anastomosis
  • Target vessel diameter is ≥ 1.3 mm
  • Target vessel has a single wall thickness ≤ 0.75mm
  • Hemodynamically stable

Treatment and study plan

Anastomosis (C-Port® )

Device

creation of anastomoses in blood vessels and grafts, including use in coronary artery bypass grafting procedures

Other names: C-Port® Distal Anastomosis System, C-Port® xA™ Distal Anastomosis System, C-Port® FlexA™ Distal Anastomosis System, C-Port® XCHANGE™ Distal Anastomosis System

Primary outcomes

  1. Graft patency rates for coronary revascularization when in general use in the United States compared to hand-sewn anastomoses.

    Time frame: 12 months

    a. Acute, midterm, and one-year graft patency rates for coronary revascularization when in general use in the United States compared to hand-sewn anastomoses.

Secondary outcomes

  1. Technical Failure Rates

    Time frame: Day 1

    Technical failure rates when completing an anastomosis using the C-Port products.

  2. Technical success rate of hand-sewn

    Time frame: Day 1 and 12 months

    The technical success rate of hand-sewn anastomoses following technical failures of the C-Port products and the hand-sewn graft patency rates and clinical sequelae at one year.

Sponsors and collaborators

Lead sponsor

Cardica, Inc

Industry

Registry information

Important dates

Study start
2009
Primary completion
2013
Study completion
2015
First posted
Nov 23, 2011
Registry last updated
Jul 22, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.